Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA2 | P00918 | 3/20 | 0.50 |
| ▸ | CA1 | P00915 | 2/20 | 0.50 |
| ▸ | PTGS1 | P23219 | 2/20 | 0.45 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.45 |
| ▸ | MAPT | P10636 | 2/20 | 0.41 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.41 |
| ▸ | HPN | P05981 | 1/20 | 0.41 |
| ▸ | SIRT5 | Q9NXA8 | 1/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.41 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.41 |
| ▸ | POLB | P06746 | 1/20 | 0.41 |
| ▸ | TYR | P14679 | 1/20 | 0.41 |
| ▸ | HSPA5 | P11021 | 2/20 | 0.40 |
| ▸ | HMGCR | P04035 | 2/20 | 0.39 |
| ▸ | NR1I2 | O75469 | 1/20 | 0.39 |
| ▸ | CYP2C9 | P11712 | 5/20 | 0.39 |
| ▸ | CYP2C19 | P33261 | 5/20 | 0.39 |
| ▸ | HIF1A | Q16665 | 4/20 | 0.39 |
| ▸ | TSHR | P16473 | 4/20 | 0.39 |
| ▸ | CYP1A2 | P05177 | 4/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL448549 | 0.90 | CA2 (0.61) | CA2CA1PTGS1PTGS2MAPT | |
| SCHEMBL15064757 | 0.86 | PTGS1 (0.48) | CA2CA1PTGS1PTGS2MAPT | |
| SCHEMBL15064805 | 0.84 | CA2 (0.46) | CA2CA1PTGS1MAPTALOX15 | |
| SCHEMBL10951644 | 0.84 | CYP2C9 (0.53) | CA2CA1PTGS1PTGS2MAPT | |
| SCHEMBL10613533 | 0.82 | HSPA5 (0.61) | CA2CA1PTGS1PTGS2MAPT | |
| SCHEMBL15064910 | 0.81 | CA2 (0.46) | CA2CA1PTGS1PTGS2MAPT | |
| SCHEMBL29602570 | 0.79 | CA2 (0.80) | CA2CA1PTGS1PTGS2MAPT | |
| SCHEMBL240515 | 0.79 | CA2 (0.80) | CA2CA1PTGS1PTGS2MAPT | |
| SCHEMBL11778040 | 0.78 | GLRA3 (0.46) | CA2CA1PTGS1PTGS2MAPT | |
| SCHEMBL2288807 | 0.78 | CA1 (0.41) | CA2CA1PTGS1PTGS2MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0509740-B1 | Heat-developable photosensitive material and image forming method making use of the heat-developable photosensitive material | CANON KK (JP) | 1996-06-26 | — | — | EP | claimed |
| EP-2797938-B1 | METHOD FOR PRODUCING 6-CHLORODIBENZO [D,F][1,3,2]DIOXAPHOSPHEPIN | BASF SE (DE) | 2016-06-01 | — | — | EP | disclosed |
| EP-2797938-A1 | METHOD FOR PRODUCING 6-CHLORODIBENZO [D,F][1,3,2]DIOXAPHOSPHEPIN | BASF SE (DE) | 2014-11-05 | — | — | EP | disclosed |
| US-8841474-B2 | Process for preparing 6-chlorodibenzo[D,F][1,3,2]dioxaphosphepin | BASF SE (DE) | 2014-09-23 | — | — | US | disclosed |
| WO-2013098371-A1 | METHOD FOR PRODUCING 6-CHLORODIBENZO [D,F][1,3,2]DIOXAPHOSPHEPIN | BASF SE (DE) | 2013-07-04 | — | — | WO | disclosed |
| US-20130172596-A1 | PROCESS FOR PREPARING 6-CHLORODIBENZO[D,F][1,3,2]DIOXAPHOSPHEPIN | BASF SE (DE) | 2013-07-04 | — | — | US | disclosed |
| US-5910600-A | Bisphosphite compound, process for its production and hydroformylation process employing the bisphosphite compound | MITSUBISHI CHEMICAL CORPORATION (JP) | 1999-06-08 | — | — | US | disclosed |
| EP-0509740-B1 | Heat-developable photosensitive material and image forming method making use of the heat-developable photosensitive material | CANON KK (JP) | 1996-06-26 | — | — | EP | disclosed |
| US-5262295-A | Biphenyldihydroxide reducing agent for silver halide emulsion layers | CANON KABUSHIKI KAISHA (JP) | 1993-11-16 | — | — | US | disclosed |
| EP-0509740-A1 | Heat-developable photosensitive material and image forming method making use of the heat-developable photosensitive material | CANON KABUSHIKI KAISHA (JP) | 1992-10-21 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130172596-A1 | PROCESS FOR PREPARING 6-CHLORODIBENZO[D,F][1,3,2]DIOXAPHOSPHEPIN | DCPS, PLCB3, DDT | CA2 826/4885CA1 535/4885PTGS1 2693/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.